What are the typical presentations of Multiple Sclerosis (MS) in a 50-year-old female?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Multiple sclerosis (MS) in a 50-year-old female typically presents with neurological symptoms such as vision problems, muscle weakness, fatigue, balance problems, and coordination difficulties, and diagnosis involves MRI imaging and cerebrospinal fluid analysis, with treatment focusing on disease-modifying therapies and symptom management. The clinical presentation of MS can vary depending on the areas of the central nervous system affected, with common symptoms including optic neuritis, muscle weakness or numbness in limbs, fatigue, balance problems, and coordination difficulties, as well as electric-shock sensations when bending the neck (Lhermitte's sign) or problems with bladder control 1. At the age of 50, MS often follows a progressive course rather than the relapsing-remitting pattern more common in younger patients, and the presentation in older females often differs from younger patients because the inflammatory component may be less prominent while neurodegenerative processes become more significant 1. Some key points to consider in the diagnosis of MS in a 50-year-old female include:

  • The clinical syndrome should be typical of demyelination, with special care needed in patients over 50 years or with vascular risk factors, who may require more stringent criteria for diagnosis 1
  • MRI studies should be of adequate quality, with few artefacts and performed on scanners with a minimum field strength of 1.5 T, and should include T2-weighted and T1 post-gadolinium images of the brain and spinal cord 1
  • Lesions should be confirmed on multiple planes to avoid false positive findings due to artefacts and false negative results, and serial imaging can support the diagnosis of MS by showing the accrual of lesions over time and in new areas of the CNS 1
  • Treatment would focus on disease-modifying therapies such as ocrelizumab (Ocrevus), siponimod (Mayzent), or cladribine (Mavenclad), which are particularly effective for older patients with progressive forms, as well as symptom management with medications like baclofen for spasticity, amantadine for fatigue, and anticholinergics for bladder dysfunction. It is also important to note that the diagnosis of MS should be made by trained clinicians or radiologists familiar with the features of MS and disorders considered in the differential diagnosis, and that the pattern of gadolinium-enhancement in MS lesions is variable but almost always transient 1.

From the Research

Typical Presentations of Multiple Sclerosis (MS) in a 50-year-old Female

The typical presentations of Multiple Sclerosis (MS) can vary, but some common forms and symptoms are:

  • Relapsing remitting MS (RRMS), which is the most common form of MS, characterized by relapses or exacerbations followed by periods of remission 2
  • Secondary progressive MS, which is a slowly progressive deterioration in neurological function that may evolve from RRMS 2
  • Primary progressive MS, which is a slow deterioration from onset without relapses or remissions, occurring in about 10-15% of people with MS 2
  • Optic neuritis, spinal cord symptoms, sensory symptoms, Lhermitte's symptom, and brainstem symptoms are common sites and symptoms of MS 2
  • A progressive spastic paraparesis or cerebellar syndrome may be suspected in patients with primary progressive MS 2

Factors Associated with Favourable Prognosis

Factors associated with a favourable prognosis in MS include:

  • Female sex 2
  • Onset with optic neuritis or sensory symptoms (rather than weakness or ataxia) 2
  • A long interval between initial relapses 2

Disease-Modifying Therapies

Disease-modifying therapies (DMTs) such as interferon beta, glatiramer acetate, fingolimod, natalizumab, and alemtuzumab may be used to reduce the rate of relapse in MS 2, 3

  • Initial treatment with fingolimod, alemtuzumab, or natalizumab may be associated with a lower risk of conversion to secondary progressive MS compared to initial treatment with glatiramer acetate or interferon beta 3
  • Early treatment with DMTs may be associated with a lower risk of conversion to secondary progressive MS 3

Other Presentations

Other presentations of MS may include:

  • Numb chin syndrome, which may be an initial presenting syndrome of MS 4
  • Neuropsychiatric syndromes, which may occur frequently in individuals with MS, either as the initial presenting complaint or with disease progression 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Diagnosing and managing multiple sclerosis.

The Practitioner, 2009

Research

["Numb chin syndrome": first presenting syndrome of multiple sclerosis?].

Deutsche medizinische Wochenschrift (1946), 2008

Research

Neuropsychiatric syndromes of multiple sclerosis.

Journal of neurology, neurosurgery, and psychiatry, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.